Krystal Biotech CEO Krish S. Krishnan sells USD 7.59 million in common shares
KRYS•CEO sells 25,000 shares in September transaction
Krish S. Krishnan, president, CEO and director, sold 25,000 Krystal Biotech common shares on Sept. 4, 2026.
Sales prices clustered around USD 354.54 to USD 366.56 per share.
Direct holdings fell to 1,347,543 shares.
He also reported indirect holdings of 217,710 shares through trusts.




